BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 9, 2003
View Archived Issues
Mice Stripped Of Dysferlin Protein Got Muscular Dystrophy, Not Able To Vulcanize Pierced Musculature
Read More
Americans Wary Of Prescription Drugs Coming In From Canada
Read More
Innodia Licenses Diabetes Product From Neurochem, Closes Series A
Read More
Other News To Note
Read More
Guilford Licenses Inhibitor Class To Pfizer As Part Of Broad Deal
Guilford Pharmaceuticals Inc. is licensing an entire class of potential neurodegenerative disease drugs to Pfizer Inc. for $5 million up front in a deal that could become much more lucrative down the road. (BioWorld Today)
Read More
PDL's Asthma Therapy Fizzles; Expected After Nuvance Failure
Read More